ArticleInternational journal of clinical pharmacy2025

Cost-benefit analysis of pharmacist early active consultation in patients with multidrug-resistant bacteria in China.

Xuefeng Shan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.